Treatment of Negative Symptoms of Schizophrenia by rTMS

Recruiting N/A Interventional Study
Schizophrenia Negative Symptoms in Schizophrenia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
124 (estimated)
Sponsor
Centre hospitalier de Ville-Evrard, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient over 18 years of age * Patient diagnosed with schizophrenia according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorder V5, 2013) * Stable drug treatment for at least 4 weeks * Presence or persistence of negative symptoms in the foreground: N…
Contacts

Youcef Bencherif

+33 1 43 09 32 32

urc@epsve.fr

CONTACT